Letter to the editorRoutine data linkage to identify and monitor diabetes in clozapine-treated patients with schizophrenia
Section snippets
Role of funding source
Not applicable.
Contributors
RP and DJS designed the study. RP and DJS managed the analyses. RP wrote the first draft of the manuscript. All authors contributed to and have approved the final manuscript.
Conflict of interest
All authors declared no competing interests.
Acknowledgements
There were no additional acknowledgements.
References (11)
- et al.
Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication
Schizophr. Res.
(2006) - et al.
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls
Schizophr. Res.
(2005) - et al.
Clinical trial of wellness training: health promotion for severely mentally ill adults
J. Nerv. Ment. Dis.
(2008) Clozapine and agranulocytosis: re-assessing the risks
Australasian Psychiatry.
(2013)- et al.
Clozapine versus typical neuroleptic medication for schizophrenia
Cochrane Database Syst. Rev.
(2009)
There are more references available in the full text version of this article.
Cited by (0)
Crown Copyright © 2016 Published by Elsevier B.V. All rights reserved.